Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma

Despite prolong exposure to revlimid, there was no delay in engraftment (blood count recovery) after autotransplant http://t.co/laJrkoPRD7

Despite prolong exposure to revlimid, stem cell collection was adequate for two autotransplants in myeloma patients http://t.co/laJrkoPRD7

Despite prolong exposure to revlimid, there was no delay in engraftment (blood count recovery) after autotransplant http://t.co/laJrkoPRD7

Despite prolong exposure to revlimid, stem cell collection was adequate for two autotransplants in myeloma patients http://t.co/laJrkoPRD7

Revlimid-based induction can impact on stem cell mobilization in patients with multiple #myeloma (http://t.co/HBMpazda3r).

Despite prolong exposure to revlimid, there was no delay in engraftment (blood count recovery) after autotransplant http://t.co/laJrkoPRD7

Despite prolong exposure to revlimid, stem cell collection was adequate for two autotransplants in myeloma patients http://t.co/laJrkoPRD7

Revlimid-based induction can impact on stem cell mobilization in patients with multiple #myeloma (http://t.co/HBMpazda3r).

Despite prolong exposure to revlimid, there was no delay in engraftment (blood count recovery) after autotransplant http://t.co/laJrkoPRD7

Despite prolong exposure to revlimid, stem cell collection was adequate for two autotransplants in myeloma patients http://t.co/laJrkoPRD7

Revlimid-based induction can impact on stem cell mobilization in patients with multiple #myeloma (http://t.co/HBMpazda3r).